Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search
 

Klaralven

(7,510 posts)
Fri Jan 22, 2021, 11:54 AM Jan 2021

New SARS-CoV-2 Variant Could Evade Antibodies

In recent months, as the global COVID-19 pandemic rages on, new variants of SARS-CoV-2 have sparked concerns about whether existing vaccines will perform as well against the evolving virus as they did in clinical trials. Three preprints posted on bioRxiv on January 19 shed some light on this question, finding that serum from vaccinated people was able to neutralize a virus with some of the same mutations as one now-widespread variant, B.1.1.7, but was less effective in neutralizing strains mimicking another variant known as 501Y.V2.

One study investigated the effects of some mutations in the 501Y.V2 variant that emerged from South Africa, using serum samples from a small pool of people who had received either the Moderna or Pfizer/BioNTech vaccine. These samples were exposed to synthetic viruses containing some of that variant’s mutations. The 501Y.V2-like variants were able to evade the antibodies more effectively than other variants were, requiring an eightfold increase in the number of antibodies needed to neutralize it. However, the results come from samples obtained from only 44 people and lacked diversity in age and race, which are two crucial factors in COVID-19 outcomes, Drew Weissman, an infectious disease expert who worked on vaccine development, tells the Associated Press.

“The data do raise the possibility that the protection gained from past infection with COVID-19 may be lower for re-infection with the South African variant,” Liam Smeeth, an epidemiologist at the London School of Hygiene and Tropical Medicine who was not involved in the study, tells Reuters. “The data also suggest that the existing vaccines could be less effective against the South African variant.”

In another study, serum samples from 16 people who had received the Pfizer vaccine were exposed to a virus with 10 mutations found in the spike protein of B.1.1.7, often called the UK variant. The synthesized pseudovirus was easily neutralized by antibodies in the samples, keeping hopes about vaccine efficacy high for this variant.

The third study used serum samples from 20 people who had received either the Moderna or Pfizer/BioNTech vaccine to explore how vaccine-induced immunity stood up to specific mutations that affect the spike protein. Although antibodies against SARS-CoV-2 wane as time goes on following infection, B cells retain the ability to target spike proteins and receptor binding domains which is part of the spike that allows the virus to attach to cells for infection. The efficacy of the serum was diminished against the pseudoviruses carrying the mutations compared with those with the dominant SARS-CoV-2 spike protein, and the samples neutralized the viral threat with a one- to threefold increase in antibodies.

https://www.the-scientist.com/news-opinion/new-sars-cov-2-variant-could-evade-antibodies-68375

6 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
New SARS-CoV-2 Variant Could Evade Antibodies (Original Post) Klaralven Jan 2021 OP
Fock. CentralMass Jan 2021 #1
I second the Fock. pdxflyboy Jan 2021 #2
KnR n/t Hugin Jan 2021 #3
From my understanding, serum was not found to be an effective treatment against covid. IsItJustMe Jan 2021 #4
More Speculative Doomsaying RobinA Jan 2021 #5
I am not a scientist, but, it seems to me that if it took them two days, IsItJustMe Jan 2021 #6

IsItJustMe

(7,012 posts)
4. From my understanding, serum was not found to be an effective treatment against covid.
Fri Jan 22, 2021, 12:39 PM
Jan 2021

So, I really don't understand why they are using serum in these experiments to begin with, even if
the serum is from people that have been vaccinated. What do these experiments really prove if
serum is not effective to begin with.

Seems like the only true and accurate results would be found by determining how many people get this
variant of this covid strain after they have being fully vaccinated.

RobinA

(9,950 posts)
5. More Speculative Doomsaying
Fri Jan 22, 2021, 01:25 PM
Jan 2021

about COVID and the vaccines. They want people to get vaccinated, but they consistently raise doubts about the vaccine. If you are vaccinated you might still be able to get COVID or spread it, so continue to stay home, social distance and wear your mask. Even if it works now, it may not work soon when the mutated viruses get here. OK, so why am I getting this brand new, created in a hurry vaccine? It might not work for me, I could still spread the virus, and soon it won't work at all. If it does now. Why would people who are the least bit skeptical about vaccines in general, or this one in particular, want to race out and get it?

And in full disclosure, I have been fully vaccinated for two weeks now with the Pfizer version.

IsItJustMe

(7,012 posts)
6. I am not a scientist, but, it seems to me that if it took them two days,
Sat Jan 23, 2021, 09:32 PM
Jan 2021

as has been reported, to create the existing vaccine that we are being given,
then why couldn't they rework the existing vaccine to include these variants.

That is how the yearly flu shot works.

Latest Discussions»General Discussion»New SARS-CoV-2 Variant Co...